Air Sentry will be showing its specialised range of clinical ventilation and monitoring solutions – widely used across the NHS since 2003 – in Manchester.
The company’s systems are also deployed by the Ministry of Justice in medical areas within prisons. Air Sentry describes its Air Purification System as 'a true system able to both interface with HVAC, or operate in a standalone capacity'.
Purpose-designed for existing clinical areas, it supplements both naturally and mechanically ventilated environments. Its unique ULPA15-based design safely removes all known pathogens from the air and is ideally suited for HCID (high consequence infectious disease) planning. The filtration system can also remove NOx, VOCs, and most reactive anaesthetic agents, while delivering both positive and negative pressure differential. It offers absolute assurance to NHS professionals with regard to air biosecurity and is fully compliant with HTM03.01. Due to its defence origins the system also has potential to aid trust Civil Defence (CBRN) preparedness.
The Genesis low level extract unit is a rapid ‘fit and forget’ solution that standardises low-level extract installation. It can be configured with recirculation, supply air integration, or temporary deployment during construction projects to mitigate airborne risk.
At the heart of Air Sentry’s digital innovation is Aristotle – a hybrid AHU/IAQ command and control system recently launched after 6 years worth of development. Described as 'an extensive AHU control system married with a distal sensing IAQ monitoring system', Aristotle enables full command and control of ventilation parameters, comprehensive data logging with 25-year retention, and client-owned data integrity. It can be deployed across new or legacy AHUs, delivering modern standards through integration with electronically commutated motors.
Air Sentry has now extended its monitoring ecosystem to include Torsa monitoring solutions – delivering intelligent, building-wide IAQ and environmental oversight – and Aranet wireless monitoring solutions, offering scalable, flexible, and precise sensing across clinical and non-clinical estates. Together with Aristotle, these platforms provide complete visibility and risk mitigation for indoor air, including pathogens, N₂O (Entonox), NOx, PM2.5, PM10 and a wide range of other air related or radiation linked requirements, including radon gas.
Future development includes disease risk alerting, supporting customers in preventing and controlling seasonal outbreaks. Combined with high-efficacy NOx filtration, Air Sentry says 'the indoor air quality of any clinical area can be absolutely assured'.
The company also offers the Elgin Bay UVC germicidal units for existing AHUs, assuring a log 4 reduction at discharge, and a range of kitchen extract hoods designed to reduce fat deposition and enable demand-led ventilation – with ROI achievable in as little as 18 months.
Air Sentry will be exhibiting on Stand C36.
